Natera named Healthcare Technology Company of the Year
03.17.26
Features

At this year’s NYC Awards Night, we had the privilege of recognizing several exceptional companies driving innovation across healthcare technology.

Congratulations to Natera on being named Healthcare Technology Company of the Year.

Natera is a global leader in cell-free DNA (cfDNA) testing, advancing precision medicine across oncology, women’s health, and organ health. Through its proprietary molecular and bioinformatics technologies, the company enables highly sensitive, non-invasive genetic testing designed to help clinicians detect disease earlier. 

From tumor-informed cancer monitoring to prenatal genetic screening and transplant assessment technologies, Natera continues to expand what’s possible in molecular diagnostics—supporting more informed care decisions and better outcomes for patients and families.

Representing the company at the event, Oded Wohl, Vice President of Product Management, accepted the award on behalf of the Natera team., Oded shared: “One of our core values at Natera is ‘a patient behind every sample.’ This carries great weight, as we all know that each sample processed in our lab represents an individual or family seeking answers for their care. We take this very seriously. We accept this award on their behalf, along with the more than 6,000 employees at Natera who are deeply committed to the same mission.”

Please join us in congratulating the Natera team on this well-deserved recognition.

The next GrowthCap Forum event will take place this summer in Jackson Hole, WY. Learn more here.

Picture: Oded Wohl speaks at NYC Awards Night

NYCAN 2026

Growth Investor Weekly

Discover unique insights from growth investors and leading executives.

Sign up for our weekly newsletter.

Top Go Back
© GrowthCap, LLC. All rights reserved.

Sign up for GrowthCap Insights